Ye J, Esmon C T, Johnson A E
Department of Chemistry and Biochemistry, University of Oklahoma, Norman 73019.
J Biol Chem. 1993 Feb 5;268(4):2373-9.
The role of the chondroitin sulfate moiety of thrombomodulin (TM) in the binding of thrombin to TM has been examined using fluorescent derivatives of thrombin. An anilinonaphthalene-6-sulfonic acid (ANS) dye was attached covalently to the active site histidine of thrombin via a D-Phe-Pro-Arg (FPR) linkage to form ANS-FPR-thrombin. When ANS-FPR-thrombin was titrated with TM lacking the chondroitin sulfate moiety (csf-TM), a monotonic and saturable increase in ANS emission intensity was observed that was consistent with the formation of a high affinity 1:1 thrombin-csf-TM complex. In contrast, titration of ANS-FPR-thrombin with intact TM containing the chondroitin sulfate resulted in a biphasic change in ANS-FPR-thrombin emission intensity that was consistent with each molecule of TM binding at least two molecules of ANS-FPR-thrombin with different affinities. This suggested that the second thrombin binds to TM via the chondroitin sulfate moiety. A direct interaction between thrombin and chondroitin sulfate was demonstrated by showing that chondroitin sulfate, cleaved and purified from TM, caused a saturable increase in ANS emission intensity upon addition to an ANS-FPR-thrombin sample. This spectral change was reversed by adding an excess of unmodified thrombin. The minimum Kd for the ANS-FPR-thrombin-chondroitin sulfate complex was approximately 20 nM, consistent with chondroitin sulfate being the lower affinity binding site on TM for thrombin. The titration of chondroitin sulfate into ANS-FPR-thrombin samples in the absence and presence of a TM fragment containing the fifth and sixth growth factor-like domains (GF5-6) showed that GF5-6 did not block chondroitin sulfate binding and that a GF5-6-thrombin-chondroitin sulfate ternary complex was formed. Thus, the chondroitin sulfate binds to thrombin somewhere other than anion-binding exosite I, and in doing so, alters the structure and/or environment of the active site more than 15A from the active site serine without detectably changing the conformation near Ser-195. Since excess TM and excess csf-TM increased the ANS emission intensity of ANS-FPR-thrombin to different extents (approximately 15 and approximately 80%, respectively), the chondroitin sulfate also influences the environment of the active site probe even when thrombin is bound to the higher affinity site on TM (GF5-6).
已使用凝血酶的荧光衍生物研究了血栓调节蛋白(TM)的硫酸软骨素部分在凝血酶与TM结合中的作用。通过D-苯丙氨酸-脯氨酸-精氨酸(FPR)连接将1-苯胺基萘-6-磺酸(ANS)染料共价连接到凝血酶的活性位点组氨酸上,形成ANS-FPR-凝血酶。当用缺乏硫酸软骨素部分的TM(csf-TM)滴定ANS-FPR-凝血酶时,观察到ANS发射强度呈单调且可饱和增加,这与形成高亲和力的1:1凝血酶-csf-TM复合物一致。相比之下,用含有硫酸软骨素的完整TM滴定ANS-FPR-凝血酶会导致ANS-FPR-凝血酶发射强度呈双相变化,这与每个TM分子结合至少两个具有不同亲和力的ANS-FPR-凝血酶分子一致。这表明第二个凝血酶通过硫酸软骨素部分与TM结合。通过证明从TM切割并纯化的硫酸软骨素在添加到ANS-FPR-凝血酶样品中时会导致ANS发射强度可饱和增加,证实了凝血酶与硫酸软骨素之间的直接相互作用。加入过量的未修饰凝血酶可逆转这种光谱变化。ANS-FPR-凝血酶-硫酸软骨素复合物的最小解离常数(Kd)约为20 nM,这与硫酸软骨素是TM上凝血酶的低亲和力结合位点一致。在不存在和存在包含第五和第六个生长因子样结构域(GF5-6)的TM片段的情况下,将硫酸软骨素滴定到ANS-FPR-凝血酶样品中表明,GF5-6不会阻断硫酸软骨素的结合,并且形成了GF5-6-凝血酶-硫酸软骨素三元复合物。因此,硫酸软骨素在阴离子结合外位点I以外的其他位置与凝血酶结合,并且这样做时,会改变活性位点丝氨酸15Å以外的活性位点结构和/或环境,而不会明显改变Ser-195附近的构象。由于过量的TM和过量的csf-TM分别将ANS-FPR-凝血酶的ANS发射强度提高到不同程度(分别约为15%和约80%),即使凝血酶与TM上的高亲和力位点(GF5-6)结合,硫酸软骨素也会影响活性位点探针的环境。